FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2738205912> ?p ?o ?g. }

• W2738205912 endingPage "26664" @default.
• W2738205912 startingPage "26648" @default.
• W2738205912 abstract "Multidrug resistance (MDR) and metastasis are the major obstacles in cancer chemotherapy. Nanotechnology-based combination therapy is a useful strategy. Recently, the combination of biologics and small drugs has attracted much attention in cancer therapy. Yet, the treatment outcomes are often compromised by the different pharmacokinetic profiles of the co-administered drugs thus leading to inconsistent drug uptake and suboptimal drug combination at the tumor sites. Nanotechnology-based co-delivery offers a promising method to address this problem, which is well demonstrated in the use of small drug combinations. However, co-delivery of the drugs bearing different physicochemical properties (e.g., proteins and small drugs) remains a formidable challenge. Herein, we developed a self-assembled nanosystem for co-delivery of trichosanthin (TCS) protein and albendazole (ABZ) as a combination therapy for overcoming MDR and metastasis. TCS is a ribosome-inactivating protein with high antitumor activity. However, the druggability of TCS is poor due to its short half-life, lack of tumor-specific action, and low cell uptake. ABZ is a clinically used antihelmintic drug, which can also inhibit tubulin polymerization and thus serve as a potential antitumor drug. In our work, ABZ was encapsulated in the albumin-coated silver nanoparticles (termed ABZ@BSA/Ag NP). The thus-formed NPs were negatively charged and could tightly bind with the cationic TCS that was modified with a cell-penetrating peptide (CPP) low-molecular-weight protamine (termed rTL). Via the stable charge interaction, the nanosystem (rTL/ABZ@BSA/Ag NP) was self-assembled, and featured by the TCS corona. The co-delivery system efficiently inhibited the proliferation of the drug-resistant tumor cells (A549/T and HCT8/ADR) by impairing the cytoskeleton, arresting the cell cycle, and enhancing apoptosis. In addition, the migration and invasion of tumor cells were inhibited presumably due to the impeded cytoskeleton functions. The anti-MDR effect was further confirmed by the in vivo studies with the subcutaneous A549/T tumor mouse model. More importantly, the co-delivery system was demonstrated to be able to inhibit metastasis. The co-delivery system of TCS/ABZ provided a potential strategy for both overcoming drug resistance and inhibiting tumor metastasis." @default.
• W2738205912 created "2017-07-31" @default.
• W2738205912 creator A5008737588 @default.
• W2738205912 creator A5011687047 @default.
• W2738205912 creator A5017806027 @default.
• W2738205912 creator A5019934303 @default.
• W2738205912 creator A5024351929 @default.
• W2738205912 creator A5046973225 @default.
• W2738205912 creator A5048123391 @default.
• W2738205912 creator A5069525077 @default.
• W2738205912 creator A5074140059 @default.
• W2738205912 creator A5074706280 @default.
• W2738205912 date "2017-08-03" @default.
• W2738205912 modified "2023-10-16" @default.
• W2738205912 title "Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis" @default.
• W2738205912 cites W1587423226 @default.
• W2738205912 cites W1951612395 @default.
• W2738205912 cites W1965844171 @default.
• W2738205912 cites W1971557671 @default.
• W2738205912 cites W1977605192 @default.
• W2738205912 cites W2002556927 @default.
• W2738205912 cites W2010856476 @default.
• W2738205912 cites W2014872524 @default.
• W2738205912 cites W2026512493 @default.
• W2738205912 cites W2030141620 @default.
• W2738205912 cites W2030147142 @default.
• W2738205912 cites W2037555314 @default.
• W2738205912 cites W2044210828 @default.
• W2738205912 cites W2056772956 @default.
• W2738205912 cites W2062807002 @default.
• W2738205912 cites W2063891273 @default.
• W2738205912 cites W2067888086 @default.
• W2738205912 cites W2072853614 @default.
• W2738205912 cites W2076825931 @default.
• W2738205912 cites W2087000836 @default.
• W2738205912 cites W2088719505 @default.
• W2738205912 cites W2095319004 @default.
• W2738205912 cites W2096526911 @default.
• W2738205912 cites W2096568160 @default.
• W2738205912 cites W2121576598 @default.
• W2738205912 cites W2139891037 @default.
• W2738205912 cites W2163255644 @default.
• W2738205912 cites W2165921162 @default.
• W2738205912 cites W2168788695 @default.
• W2738205912 cites W2169829820 @default.
• W2738205912 cites W2190725551 @default.
• W2738205912 cites W2215236428 @default.
• W2738205912 cites W2324912006 @default.
• W2738205912 cites W2409603104 @default.
• W2738205912 cites W2545488154 @default.
• W2738205912 cites W2555156914 @default.
• W2738205912 cites W2557030783 @default.
• W2738205912 cites W2581885965 @default.
• W2738205912 cites W2588435629 @default.
• W2738205912 cites W4247394081 @default.
• W2738205912 doi "https://doi.org/10.1021/acsami.7b05292" @default.
• W2738205912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28741923" @default.
• W2738205912 hasPublicationYear "2017" @default.
• W2738205912 type Work @default.
• W2738205912 sameAs 2738205912 @default.
• W2738205912 citedByCount "78" @default.
• W2738205912 countsByYear W27382059122018 @default.
• W2738205912 countsByYear W27382059122019 @default.
• W2738205912 countsByYear W27382059122020 @default.
• W2738205912 countsByYear W27382059122021 @default.
• W2738205912 countsByYear W27382059122022 @default.
• W2738205912 countsByYear W27382059122023 @default.
• W2738205912 crossrefType "journal-article" @default.
• W2738205912 hasAuthorship W2738205912A5008737588 @default.
• W2738205912 hasAuthorship W2738205912A5011687047 @default.
• W2738205912 hasAuthorship W2738205912A5017806027 @default.
• W2738205912 hasAuthorship W2738205912A5019934303 @default.
• W2738205912 hasAuthorship W2738205912A5024351929 @default.
• W2738205912 hasAuthorship W2738205912A5046973225 @default.
• W2738205912 hasAuthorship W2738205912A5048123391 @default.
• W2738205912 hasAuthorship W2738205912A5069525077 @default.
• W2738205912 hasAuthorship W2738205912A5074140059 @default.
• W2738205912 hasAuthorship W2738205912A5074706280 @default.
• W2738205912 hasConcept C114851261 @default.
• W2738205912 hasConcept C133936738 @default.
• W2738205912 hasConcept C171250308 @default.
• W2738205912 hasConcept C185592680 @default.
• W2738205912 hasConcept C192562407 @default.
• W2738205912 hasConcept C2776624327 @default.
• W2738205912 hasConcept C2779820397 @default.
• W2738205912 hasConcept C2780035454 @default.
• W2738205912 hasConcept C502942594 @default.
• W2738205912 hasConcept C55493867 @default.
• W2738205912 hasConcept C71924100 @default.
• W2738205912 hasConcept C86803240 @default.
• W2738205912 hasConcept C89423630 @default.
• W2738205912 hasConcept C98274493 @default.
• W2738205912 hasConceptScore W2738205912C114851261 @default.
• W2738205912 hasConceptScore W2738205912C133936738 @default.
• W2738205912 hasConceptScore W2738205912C171250308 @default.
• W2738205912 hasConceptScore W2738205912C185592680 @default.
• W2738205912 hasConceptScore W2738205912C192562407 @default.
• W2738205912 hasConceptScore W2738205912C2776624327 @default.

• next